Search clinical trials for: NSCLC, c-Met,
Total 59233 results
-
Abion IncRecruitingAdvanced Solid TumorsKorea, Republic of, Taiwan, United States
-
Yonsei UniversityNot yet recruiting
-
SCRI Development Innovations, LLCNovartisCompletedRenal Cell Carcinoma | Colorectal Cancer | Glioblastoma Multiforme | GliosarcomaUnited States
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.RecruitingNon Small Cell Lung CancerChina
-
Fujian Cosunter Pharmaceutical Co. LtdUnknownSolid Tumor | C-Met Mutation-Related TumorsChina
-
The Second Hospital of Nanjing Medical UniversityUnknownPrimary Hepatocellular Carcinoma
-
Samsung Medical CenterCompletedc-MET Positive Gastric CancerKorea, Republic of
-
AbbVie (prior sponsor, Abbott)CompletedAdvanced Solid Tumors
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
Novartis PharmaceuticalsTerminatedc-MET Inhibitor; PI3K Inhibitor, PTEN Mutations, Homozygous Del. of PTEN or PTEN Neg. by IHC, c-Met Ampli. by FISH, INC280, BKM120, Buparlisib; Recurrent GBMSpain, Switzerland, Germany, United States, Netherlands
-
PfizerCompletedSystemic Anaplastic Large-Cell Lymphoma | Non-Small Cell Lung Cancer ALK-positive | Non-Small Cell Lung Cancer c-Met Dependent | Non-Small Cell Lung Cancer ROS Marker Positive | Advanced Malignancies Except LeukemiaUnited States, Korea, Republic of, Australia, Japan
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorJapan
-
Haihe Biopharma Co., Ltd.RecruitingC-Met Exon 14 MutationChina, Japan, United States
-
AbbVieActive, not recruitingNon-small Cell Lung CancerUnited States, Australia, Belgium, Bulgaria, Canada, China, Czechia, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Puerto Rico, Romania, Russian Federation, Spain, Switzerland and more
-
RemeGen Co., Ltd.Recruiting
-
AmgenCompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
Duke UniversityProstate Cancer Foundation; Janssen Diagnostics, LLCCompletedRenal Cell Carcinoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Prostate Cancer | Bladder Cancer | Non-small Cell Lung Cancer | Advanced MET Amplified Solid TumorUnited States
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast CarcinomaUnited States
-
Sun Yat-sen UniversityUnknown
-
Byondis B.V.RecruitingSolid TumorBelgium, Italy, Netherlands, United Kingdom
-
University of ChileCompletedReplacement | Repair | Composites RestorationsChile
-
Daiichi Sankyo, Inc.ArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary...CompletedHepatocellular CarcinomaUnited States, France, Italy, Germany, Spain, Switzerland, Belgium, Portugal, Netherlands, Australia, Brazil, Canada, Austria, New Zealand, Sweden, Argentina
-
National Cancer Institute (NCI)TerminatedEpithelioid Mesothelioma | Sarcomatoid Mesothelioma | Stage IV Pleural Mesothelioma | Recurrent Malignant Mesothelioma | Stage II Pleural Mesothelioma | Stage III Pleural MesotheliomaUnited States
-
Liza Villaruz, MDExelixisTerminatedNon Small Cell Lung Cancer (NSCLC) | Metastases to the BrainUnited States
-
University of ChileWithdrawnKnee OsteoarthritisChile
-
Chungbuk National University HospitalMerck KGaA, Darmstadt, GermanyRecruitingSolid Tumor | MET Amplification | MET Exon 14 Skipping MutationKorea, Republic of
-
GlaxoSmithKlineCompleted
-
Armando Santoro, MDCompletedColorectal Cancer Metastatic | C-met OverexpressionItaly
-
National Cancer Institute (NCI)CompletedChildhood Solid NeoplasmUnited States, Canada
-
Apollomics (Australia) Pty. Ltd.Novotech (Australia) Pty Limited; Apollomics Inc. (formerly CBT Pharmaceuticals...TerminatedRenal Cell Carcinoma | Hepatocellular CarcinomaAustralia, New Zealand
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Southwest Oncology GroupCompletedRecurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma AJCC V7United States
-
Novartis PharmaceuticalsTerminatedAdvanced Hepatocellular Carcinoma With c-MET DysregulationChina, Hong Kong, Thailand, Singapore
-
Kyowa Kirin Co., Ltd.CompletedNon-small-cell Lung CancerJapan
-
Novartis PharmaceuticalsWithdrawnAdvanced Hepatocellular CarcinomaGermany, Australia, Hong Kong, Switzerland, Spain, France, United States
-
GlaxoSmithKlineCompletedCarcinoma, HepatocellularTaiwan, Thailand, Hong Kong
-
Dow University of Health SciencesCompletedMechanical Neck PainPakistan
-
Symphogen A/SCompletedNSCLC | Non Small Cell Lung Cancer | Oncology | MET Gene Mutation | MET Gene AmplificationUnited States, Korea, Republic of, Denmark, Hong Kong, Taiwan, Spain
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Unknown
-
The Netherlands Cancer InstituteCompletedHead and Neck Cancer | Penile CancerNetherlands
-
National Cancer Institute (NCI)CompletedRefractory Multiple MyelomaUnited States
-
Open Innovation Partners, Inc.Open Innovation PartnersSuspendedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
Novartis PharmaceuticalsCompletedSolid TumorsGermany, United States, Netherlands, Spain, Canada, Hong Kong, Italy, Singapore, Australia, Israel, Korea, Republic of, Taiwan, France, Norway, Thailand
-
NuBiyotaCompletedClostridium Difficile InfectionCanada
-
NuBiyotaUnknownObesity, Metabolically BenignCanada
-
University of KwaZuluCompletedChronic Non-specific Low Back PainNigeria
-
Louisiana State University Health Sciences Center...Columbia UniversityCompletedBreast CancerUnited States